Post-Traumatic Stress Disorder Treatment Market Growth, Size, Trends, Demand and Future Scope: SPER Market Research

Q: How can I get the sample report on the Post-Traumatic Stress Disorder Treatment Market?

You can get the sample pages by clicking the link - Click Here

Published: Dec 2022	Report ID: HLCA2234	Pages: 1 - 232	Formats^*:
Category : Healthcare

Post-Traumatic Stress Disorder Treatment Market Introduction and Overview

According to SPER Market Research, the Global Post-Traumatic Stress Disorder Treatment Market is estimated to reach USD 27.77 billion by 2032 with a CAGR of 5.14%.

The report includes an in-depth analysis of the Global Post-Traumatic Stress Disorder Treatment market, including market size and trends, product mix, distribution channels, and supplier analysis. Post-traumatic stress disorder (PTSD) can occur in persons who have encountered a significant shock, such as a natural disaster, a life-threatening event, a vehicle accident, sexual abuse, and so on. PTSD symptoms can appear three months or even a year later. Most PTSD patients have symptoms such as intrusive memories, avoidance, negative thinking changes, and altered emotional and physical responses. For example, the sudden death of a loved one may trigger PTSD in some people.

At Biomed Israel, Madrigal Mental Care demonstrated its nanotechnology for the treatment and prevention of post-traumatic stress disorder.

Mydecine Innovations Group Inc. partnered with Combat Stress and King's College London to treat post-traumatic stress disorder (PTSD) in veterans by using psilocybin in psychoactively aided psychotherapy.

Market Opportunities and Challenges

The Post-Traumatic Stress Disorder Treatment market has a variety of opportunities and challenges. On the opportunity side, the key factors driving the growth of the post-traumatic stress disorder treatment market are an increase in the prevalence of post-traumatic stress disorder globally, an increase in the number of clinical trials related to the treatment of post-traumatic stress disorder, and an increase in research and development efforts aimed at introducing novel therapies and medications. Furthermore, the market is expected to grow due to various factors, including the growing prevalence of post-traumatic stress disorder (PTSD) globally, an increase in clinical trials for PTSD treatment, and an increase in research and development of new therapies and medications for PTSD.

The high cost of care places significant restrictions on the market for post-traumatic stress disorder treatment. Post-traumatic stress disorder (PTSD) is becoming more commonplace worldwide, more clinical research is being done to treat PTSD, and more new PTSD therapies and drugs are being developed; all of these factors have led to the market's growth. Furthermore, the other obstacles impeding the growth of the post- Traumatic Stress Disorder treatment market, however, are the adverse effects of treatment for post-traumatic stress disorder and its high cost.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

The market for treatments for post-traumatic stress disorder is crowded, with many domestic and foreign competitors. To improve their market presence, the major players are implementing a variety of growth tactics, including alliances, partnerships, joint ventures, new product launches, geographic expansions, mergers, and acquisitions. Lupin Limited, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, and Merck KGaA are a few of the major companies in the industry.

Scope of the Report:

Report Metric	Details
Market size available for years	2019-2032
Base year considered	2021
Forecast period	2022-2032
Segments covered	By Drug Type, By Age Group, By Distribution Channel, By End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered	Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.

COVID-19 Impact on Global Post-Traumatic Stress Disorder Treatment Market

The market for posttraumatic stress disorder (PTSD) treatment has been severely affected by the COVID-19 pandemic, an unprecedented health hazard. Numerous research have demonstrated that COVID-19 raises the risk of PTSD, and as a result, there is a growing need for PTSD treatment. For example, a review article published in August 2021 titled "COVID-19 and Posttraumatic Stress Disorder: The Perfect 'Storm' for Mental Health (Review)" showed that COVID-19 has a major effect on mental health and increases the risk of developing trauma-related disorders, including PTSD, in those who are most susceptible, such as children, adolescents, and adult COVID-19 survivors.

Key Target Audience

Hospitals
Mental Health Centre
Outpatient Clinics

Our in-depth analysis of the Post-Traumatic Stress Disorder Treatment Market includes the following segments:

By Drug Type:	Anti-anxiety Antidepressants Antipsychotics Beta-blockers Monoamine Oxidase Others
By Age Group:	Paediatrics Geriatrics Adults
By Distribution Channel:	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By End User:	Mental Health Center Hospitals Outpatient Clinics Others
By Region:	Asia-Pacific Europe Middle East & Africa North America South America

Key Topics Covered in the Report

Global Post-Traumatic Stress Disorder Treatment Market Size (FYâ€™2022-FYâ€™2032)
Overview of Global Post-Traumatic Stress Disorder Treatment Market
Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Drug Type (Anti-anxiety, Antidepressants, Antipsychotics, Beta-blockers, Monoamine Oxidase, Others)
Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Age Group (Paediatrics, Geriatrics, Adults)
Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By End User (Mental Health Centre, Hospitals, Outpatient Clinics, Others) Statistical Snap of Global Post-Traumatic Stress Disorder Treatment Market
Expansion Analysis of Global Post-Traumatic Stress Disorder Treatment Market
Problems and Obstacles in Global Post-Traumatic Stress Disorder Treatment Market
Competitive Landscape in the Global Post-Traumatic Stress Disorder Treatment Market
Impact of COVID-19 and Demonetization on Global Post-Traumatic Stress Disorder Treatment Market
Details on Current Investment in Global Post-Traumatic Stress Disorder Treatment Market
Competitive Analysis of Global Post-Traumatic Stress Disorder Treatment Market
Prominent Players in the Global Post-Traumatic Stress Disorder Treatment Market
SWOT Analysis of Global Post-Traumatic Stress Disorder Treatment Market
Global Post-Traumatic Stress Disorder Treatment Market Future Outlook and Projections (FYâ€™2022-FYâ€™2032)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source

2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPERâ€™s internal database
2.1.4 Premium insight from KOLâ€™s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

4.2. COVID-19 Impacts of the Global Post-Traumatic Stress Disorder Treatment Market

5. Market variables and outlook

5.1. SWOT analysis

5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats

5.2. PESTEL analysis

5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape

5.3. PORTERâ€™S five forces analysis

5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry

5.4. Heat map analysis

6. Competitive Landscape

6.1 Global Post-Traumatic Stress Disorder Treatment Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Post-Traumatic Stress Disorder Treatment Market

7. Global Post-Traumatic Stress Disorder Treatment Market, By DrugType, 2019-2032 (USD Million)

7.1 Anti-anxiety
7.2 Antidepressants
7.3 Antipsychotics
7.4 Beta-blockers
7.5 Monoamine Oxidase
7.6 Others

8. Global Post-Traumatic Stress Disorder Treatment Market, By Age Group, 2019-2032 (USD Million)

8.1 Paediatrics
8.2 Geriatrics
8.3 Adults

9. Global Post-Traumatic Stress Disorder Treatment Market, By Distribution Channel, 2019-2032 (USD Million)

9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies

10. Global Post-Traumatic Stress Disorder Treatment Market, By End User, 2019-2032 (USD Million)

10.1 Mental Health Center
10.2 Hospitals
10.3 Outpatient Clinics
10.4 Others

11. Global Post-Traumatic Stress Disorder Treatment Market, By Region, 2019-2032 (USD Million)

11.1 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2019-2025)
11.2 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2026-2032)
11.3 Asia-Pacific

11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific

11.4 Europe

11.4.1 France
11.4.2 Germany
11.4.3 Italy
11.4.4 Spain
11.4.5 United Kingdom
11.4.6 Rest of Europe

11.5 Middle East & Africa

11.5.1 Kingdom of Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 Rest of Middle East & Africa

11.6 North America

11.6.1 Canada
11.6.2 Mexico
11.6.3 United States

11.7 South America

11.7.1 Argentina
11.7.2 Brazil
11.7.3 Rest of South America

12. Company Profiles

12.1 Allergan PLC

12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments

12.2 Amneal Pharmaceuticals LLC

12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments

12.3 Apotex Inc.

12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments

12.4 AstraZeneca

12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments

12.5 Aurobindo Pharma

12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments

12.6 Bausch Health Companies Inc.

12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments

12.7 Bristol-Myers Squibb

12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments

12.8 Eli Lilly and Company

12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments

12.9 GlaxoSmithKline PLC

12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments

12.10 Johnson and Johnson

12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments

12.11 Mylan Pharmaceuticals

12.11.1 Company details
12.11.2 Financial outlook
12.11.3 Product summary
12.11.4 Recent developments

12.12 Pfizer Inc.

12.12.1 Company details
12.12.2 Financial outlook
12.12.3 Product summary
12.12.4 Recent developments

12.13 Sun Pharmaceuticals Pvt Ltd

12.13.1 Company details
12.13.2 Financial outlook
12.13.3 Product summary
12.13.4 Recent developments

12.14 Teva Pharmaceuticals Industries Ltd.

12.14.1 Company details
12.14.2 Financial outlook
12.14.3 Product summary
12.14.4 Recent developments

13. List of Abbreviations

14. Reference Links

15. Conclusion

16. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Post-Traumatic Stress Disorder Treatment Market?

The Post-Traumatic Stress Disorder Treatment Market is projected to reach USD 27.77 billion by 2032, growing at a CAGR of 5.14% during the forecast period.

What is the growth rate of the Post-Traumatic Stress Disorder Treatment Market?

The Post-Traumatic Stress Disorder Treatment Market grew in market size from 2021. The Market is expected to reach USD 27.77 billion by 2032, at a CAGR of 5.14% during the forecast period.

What is the anticipated CAGR of the Post-Traumatic Stress Disorder Treatment Market during the forecast period?

The Post-Traumatic Stress Disorder Treatment Market CAGR of 5.14% during the forecast period.

How can I get the sample report on the Post-Traumatic Stress Disorder Treatment Market?

You can get the sample pages by clicking the link -Click Here

What is the market size of the Post-Traumatic Stress Disorder Treatment Market?

The Post-Traumatic Stress Disorder Treatment Market size is USD 27.77 billion from 2022 to 2032.

Which segment is expected to lead the Post-Traumatic Stress Disorder Treatment Market the forecast period?

The Post-Traumatic Stress Disorder Treatment Market segment is Covered By Drug Type, By Age Group, By Distribution Channel, By End User.

Which region is expected to have the highest market share in the Post-Traumatic Stress Disorder Treatment Market?

The North America region is anticipated to have the highest market share in the Post-Traumatic Stress Disorder Treatment Market.

Who are the key players in Post-Traumatic Stress Disorder Treatment Market?

The key players in the market include Companies Covered Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.

What is the conclusion of the Post-Traumatic Stress Disorder Treatment Market?

The market for treating post-traumatic stress disorder is severely constrained by the high cost of care.The prevalence of post-traumatic stress disorder (PTSD) is rising globally, there are more clinical studies being conducted to treat PTSD, and there has been an increase in the development of new PTSD treatments and medications, all of which have contributed to the market's expansion.